Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
dotarizine voltage-dependent p/q-type calcium channel subunit alpha-1a small molecule NA drugbank Cluster Headache[MeSHID:D003027]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Cessation of life[MeSHID:D003643]
Expiration
function[MeSHID:D045853]
NA investigational unknown
dotarizine 5-hydroxytryptamine receptor 1a small molecule NA drugbank Cluster Headache[MeSHID:D003027]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Cessation of life[MeSHID:D003643]
Expiration
function[MeSHID:D045853]
NA investigational unknown
dotarizine 5-hydroxytryptamine receptor 2a small molecule NA drugbank Cluster Headache[MeSHID:D003027]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Cessation of life[MeSHID:D003643]
Expiration
function[MeSHID:D045853]
NA investigational unknown
dotarizine 5-hydroxytryptamine receptor 2c small molecule NA drugbank Cluster Headache[MeSHID:D003027]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Cessation of life[MeSHID:D003643]
Expiration
function[MeSHID:D045853]
NA investigational unknown
click here to return to the previous page